- US12473314utility2025Phospholipid Compounds and Uses Thereof0 cites
- US12459922utility2025PARP7 Inhibitors0 cites
- US12448400utility2025KRAS G12D Modulating Compounds0 cites
- US12448388utility2025PRMT5 Inhibitors and Uses Thereof0 cites
- US12448383utility2025Compounds and Methods for Treatment of Viral Infections0 cites
- US12427150utility2025Phospholipid Formulations of 1′-cyano Substituted Carba-nucleoside Analogs0 cites
- USD1094113design2025Blister Pack0 cites
- US12421235utility2025Bridged Tricyclic Carbamoylpyridone Compounds and Uses Thereof0 cites
- US12415808utility2025Pyrrolo[1,2-b]pyridazine Derivatives0 cites
- US12410146utility2025Processes and Intermediates for Preparing MCL1 Inhibitors0 cites
- US12410160utility2025KHK Inhibitors0 cites
- US12410183utility2025Sars-cov2 Main Protease Inhibitors0 cites
- US12404262utility2025Therapeutic Compounds for HIV Virus Infection0 cites
- US12404289utility20251′-cyano Nucleoside Analogs and Uses Thereof0 cites
- US12398160utility2025Cot Modulators and Methods of Use Thereof0 cites
- USD1086890design2025Blister Pack0 cites
- US12377100utility2025Toll Like Receptor Modulator Compounds0 cites
- USD1085889design2025Pouch0 cites
- US12364751utility2025HBV Vaccines and Methods Treating HBV0 cites
- US12365666utility2025Process for Preparing a Cot Inhibitor Compound0 cites